Table 4 Final set of benefit and harm outcomes deemed to be of critical or important for guideline development and decision-making
Outcome | Consideration of the benefits/harms associated with the preventive health care intervention | Priority |
|---|---|---|
All-cause mortality | • Potential benefit (reduction in) • Potential harm (increase in) | Critical |
Hospitalization | • Potential benefit (reduction in) • Potential harm (increase in) | Critical |
Non-serious (i.e., not requiring hospitalization and not causing death) adverse drug reactions including those related to withdrawal or stopping medication | • Potential benefit (reduction in) • Potential harm (increase in) | Critical |
Quality of life | • Potential benefit (increase in) • Potential harm (reduction in) | Important |
Emergency department visits | • Potential benefit (reduction in) • Potential harm (increase in) | Important |
Injurious falls | • Potential benefit (reduction in) • Potential harm (increase in) | Important |
Medical visits | • Potential benefit (reduction in) • Potential harm (increase in) | Important |
Number of medications (and number of pills) | • Potential benefit only (reduction in) | Important |